| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 3 | |
| #2 | EPO (European Patent Office) | 2 | |
| #3 | Republic of Korea | 2 | |
| #4 | Australia | 1 | |
| #5 | Canada | 1 | |
| #6 | China | 1 | |
| #7 | Israel | 1 | |
| #8 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Beltraminelli Nicola | 12 |
| #2 | Garrone Pierre | 10 |
| #3 | Preville Xavier | 8 |
| #4 | Takami Sachiko | 8 |
| #5 | Rogel Anne | 8 |
| #6 | Renart-Depontieu Florence | 7 |
| #7 | Al-Shamkhani Aymen | 7 |
| #8 | Margall-Ducos Germain | 7 |
| #9 | Fuller Steve | 2 |
| #10 | Fallot Stéphanie | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020108735A1 | Antibodies to cytomegalovirus interleukin-10 | |
| KR20200089255A | New nicotine-binding antibody | |
| AU2018315432A1 | CD96-binding agents as immunomodulators | |
| WO2017121771A1 | Humanized, mouse or chimeric anti-cd47 monoclonal antibodies |